Treatment of vascular thrombosis with enoxaparin in orthotopic heart transplant patients during the early postoperative period

John C. Lopshire, Alejandra G. Darroca, Irmina Gradus-Pizlo, Jacqueline O'Donnell

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Management of anti-coagulation in the early period after orthotopic heart transplantation, when the frequency of invasive procedures to assess for graft rejection is high, presents a difficult clinical problem in which the need for effective therapy must be weighed against the desire for outpatient treatment. In this report, we summarize the clinical course and long-term outcome of 6 patients from our center in whom vascular thrombosis was treated on an outpatient basis with enoxaparin. We conclude that the use of enoxaparin may provide a safe and reasonable alternative to conventional anti-coagulation therapy during this period.

Original languageEnglish
Pages (from-to)1025-1029
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume20
Issue number9
DOIs
StatePublished - 2001

Fingerprint

Enoxaparin
Postoperative Period
Blood Vessels
Thrombosis
Transplants
Outpatients
Graft Rejection
Heart Transplantation
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Treatment of vascular thrombosis with enoxaparin in orthotopic heart transplant patients during the early postoperative period. / Lopshire, John C.; Darroca, Alejandra G.; Gradus-Pizlo, Irmina; O'Donnell, Jacqueline.

In: Journal of Heart and Lung Transplantation, Vol. 20, No. 9, 2001, p. 1025-1029.

Research output: Contribution to journalArticle

@article{37b790fe90534bf382d8ba0859dc379a,
title = "Treatment of vascular thrombosis with enoxaparin in orthotopic heart transplant patients during the early postoperative period",
abstract = "Management of anti-coagulation in the early period after orthotopic heart transplantation, when the frequency of invasive procedures to assess for graft rejection is high, presents a difficult clinical problem in which the need for effective therapy must be weighed against the desire for outpatient treatment. In this report, we summarize the clinical course and long-term outcome of 6 patients from our center in whom vascular thrombosis was treated on an outpatient basis with enoxaparin. We conclude that the use of enoxaparin may provide a safe and reasonable alternative to conventional anti-coagulation therapy during this period.",
author = "Lopshire, {John C.} and Darroca, {Alejandra G.} and Irmina Gradus-Pizlo and Jacqueline O'Donnell",
year = "2001",
doi = "10.1016/S1053-2498(01)00284-4",
language = "English",
volume = "20",
pages = "1025--1029",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Treatment of vascular thrombosis with enoxaparin in orthotopic heart transplant patients during the early postoperative period

AU - Lopshire, John C.

AU - Darroca, Alejandra G.

AU - Gradus-Pizlo, Irmina

AU - O'Donnell, Jacqueline

PY - 2001

Y1 - 2001

N2 - Management of anti-coagulation in the early period after orthotopic heart transplantation, when the frequency of invasive procedures to assess for graft rejection is high, presents a difficult clinical problem in which the need for effective therapy must be weighed against the desire for outpatient treatment. In this report, we summarize the clinical course and long-term outcome of 6 patients from our center in whom vascular thrombosis was treated on an outpatient basis with enoxaparin. We conclude that the use of enoxaparin may provide a safe and reasonable alternative to conventional anti-coagulation therapy during this period.

AB - Management of anti-coagulation in the early period after orthotopic heart transplantation, when the frequency of invasive procedures to assess for graft rejection is high, presents a difficult clinical problem in which the need for effective therapy must be weighed against the desire for outpatient treatment. In this report, we summarize the clinical course and long-term outcome of 6 patients from our center in whom vascular thrombosis was treated on an outpatient basis with enoxaparin. We conclude that the use of enoxaparin may provide a safe and reasonable alternative to conventional anti-coagulation therapy during this period.

UR - http://www.scopus.com/inward/record.url?scp=0034853713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034853713&partnerID=8YFLogxK

U2 - 10.1016/S1053-2498(01)00284-4

DO - 10.1016/S1053-2498(01)00284-4

M3 - Article

VL - 20

SP - 1025

EP - 1029

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 9

ER -